| Long name: |
ALEXA FLUOR 350 Conjugated, CACNA1F Polyclonal Antibody |
| Also known as: |
Anti-CACNA1F PAb ALEXA FLUOR 350 |
| Category: |
Conjugated Primary Antibodies |
| Conjugated with: |
350, ALEXA FLUOR® |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
CACNA1F |
| Specificity: |
This is a highly specific antibody against CACNA1F |
| Modification: |
Unmodified |
| Modification Site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CACNA1F |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Cross-reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen: |
L-type Ca2+ currents initiate muscle contraction, L-type calcium channels may form macromolecular signaling complexes with G protein-coupled receptors, N-, P-, Q-, T-, and R- types, and can be regulated through second-messenger activated protein phosphorylation pathways, and gene transcription, and they are involved in a variety of Ca2+-dependent processes, endocrine secretion, hormone or neurotransmitter release and gene expression, including muscle contraction, thereby enhancing the selectivity of regulating specific targets, Ca2+ currents are characterized on the basis of their biophysical and pharmacologic properties and include L-, Voltage-dependent Ca2+ channels mediate Ca2+ entry into excitable cells in response to membrane depolarization |
| Purification: |
Purified by Protein A |
| Storage conditions: |
50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission: |
343nm/442nm |
| Synonyms: |
Cav1, 4 JM8 JMC8 CSNBX2 CORDX3 CSNB2A OA2 |
| Properties: |
ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 350 conjugates can be used in multi-color flow cytometry with FACS's equipped with a second red laser or red diode, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
ALEXA FLUOR 350, Alexa Fluor |
| Gene target: |
CACNA1F |
| Short name: |
CACNA1F Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Label: |
ALEXA FLUOR 350 |
| Alternative name: |
ALEXA FLUOR 350, CACNA1F (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
1393 |
| Gene: |
CACNA1F |
More about : CACNA1F |
| Long gene name: |
calcium voltage-gated channel subunit alpha1 F |
| Synonyms gene: |
CSNB2 AIED |
| Synonyms gene name: |
Aland island eye disease (Forsius-Eriksson ocular albinism, L type, alpha 1F subunit , ocular albinism type 2) calcium channel, voltage-dependent |
| Locus: |
Xp11, 23 |
| Discovery year: |
1997-04-21 |
| GenBank acession: |
AA019975 |
| Entrez gene record: |
778 |
| Pubmed identfication: |
9344658 9662400 16382099 12111638 17525176 |
| RefSeq identity: |
NM_005183 |
| Classification: |
Calcium voltage-gated channel subunits |
| Havana BLAST/BLAT: |
OTTHUMG00000022703 |
| Locus Specific Databases: |
Mutations of the L-type Calcium-Channel Gene Mental Retardation database |